Integrating High-Content Imaging and Chemical Genetics to Probe Host Cellular Pathways Critical for Yersinia Pestis Infection

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kota, Krishna P ^b   Eaton, Brett ^a   Lane, Douglas ^c   Ulrich, Melanie ^a   Ulrich, Ricky ^a   Peyser, Brian D ^c   Robinson, Camenzind G ^a   Jaissle, James G ^a   Pegoraro, Gianluca ^b   Bavari, Sina ^a   Panchal, Rekha G ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b PERKINELMER INC   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; BACTERIAL SURVIVAL; CELL STIMULATION; CONTROLLED STUDY; ENZYME ANALYSIS; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; HIGH CONTENT IMAGING; HOST PATHOGEN INTERACTION; IMAGE ANALYSIS; INTERNALIZATION; MACROPHAGE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PHAGOCYTOSIS; PLAGUE; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; SCREENING TEST;

ANIMALS; CELL LINE; DRUG EVALUATION, PRECLINICAL; MACROPHAGES; MICE; MOLECULAR IMAGING; NF-KAPPA B; PHAGOCYTOSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES; YERSINIA PESTIS;

EID: 84873870017     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055167     Document Type: Article

References (51)

1. Drevets DA, Elliott AM, (1995) Fluorescence labeling of bacteria for studies of intracellular pathogenesis. J Immunol Methods 187: 69-79.
2. Lang P, Yeow K, Nichols A, Scheer A, (2006) Cellular imaging in drug discovery. Nat Rev Drug Discov 5: 343-356.
3. Moffat J, Sabatini DM, (2006) Building mammalian signalling pathways with RNAi screens. Nat Rev Mol Cell Biol 7: 177-187.
4. Panchal RG, Kota KP, Spurgers KB, Ruthel G, Tran JP, et al. (2010) Development of high-content imaging assays for lethal viral pathogens. J Biomol Screen 15: 755-765.
5. Low J, Stancato L, Lee J, Sutherland JJ, (2008) Prioritizing hits from phenotypic high-content screens. Curr Opin Drug Discov Devel 11: 338-345.
6. MacDonald ML, Lamerdin J, Owens S, Keon BH, Bilter GK, et al. (2006) Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2: 329-337.
7. Tanaka M, Bateman R, Rauh D, Vaisberg E, Ramachandani S, et al. (2005) An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol 3: e128.
8. Caie PD, Walls RE, Ingleston-Orme A, Daya S, Houslay T, et al. (2010) High-content phenotypic profiling of drug response signatures across distinct cancer cells. Mol Cancer Ther 9: 1913-1926.
9. Fuchs F, Pau G, Kranz D, Sklyar O, Budjan C, et al. (2010) Clustering phenotype populations by genome-wide RNAi and multiparametric imaging. Mol Syst Biol 6: 370.
10. Loo LH, Wu LF, Altschuler SJ, (2007) Image-based multivariate profiling of drug responses from single cells. Nat Methods 4: 445-453.
11. Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, et al. (2004) Multidimensional drug profiling by automated microscopy. Science 306: 1194-1198.
12. Brodin P, Poquet Y, Levillain F, Peguillet I, Larrouy-Maumus G, et al. (2010) High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. PLoS Pathog 6: e1001100.
13. Christophe T, Jackson M, Jeon HK, Fenistein D, Contreras-Dominguez M, et al. (2009) High content screening identifies decaprenyl-phosphoribose 2′ epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog 5: e1000645.
14. Gurumurthy RK, Maurer AP, Machuy N, Hess S, Pleissner KP, et al. (2010) A loss-of-function screen reveals Ras- and Raf-independent MEK-ERK signaling during Chlamydia trachomatis infection. Sci Signal 3: ra21.
15. Misselwitz B, Dilling S, Vonaesch P, Sacher R, Snijder B, et al. (2011) RNAi screen of Salmonella invasion shows role of COPI in membrane targeting of cholesterol and Cdc42. Mol Syst Biol 7: 474.
16. Stenseth NC, Atshabar BB, Begon M, Belmain SR, Bertherat E, et al. (2008) Plague: past, present, and future. PLoS Med 5: e3.
17. Anderson GW Jr, Worsham PL, Bolt CR, Andrews GP, Welkos SL, et al. (1997) Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am J Trop Med Hyg 56: 471-473.
18. Benedek O, Nagy G, Emody L, (2004) Intracellular signalling and cytoskeletal rearrangement involved in Yersinia pestis plasminogen activator (Pla) mediated HeLa cell invasion. Microb Pathog 37: 47-54.
19. Cowan C, Jones HA, Kaya YH, Perry RD, Straley SC, (2000) Invasion of epithelial cells by Yersinia pestis: evidence for a Y. pestis-specific invasin. Infect Immun 68: 4523-4530.
20. Trosky JE, Liverman AD, Orth K, (2008) Yersinia outer proteins: Yops. Cell Microbiol 10: 557-565.
21. Mahalanobis PC, (1936) On the generalised distance in statistics. Proceedings of the National Institute of Sciences of India 2: 49-55.
22. Neish AS, Naumann M, (2011) Microbial-induced immunomodulation by targeting the NF-kappaB system. Trends Microbiol 19: 596-605.
23. Zhang Y, Bliska JB, (2005) Role of macrophage apoptosis in the pathogenesis of Yersinia. Curr Top Microbiol Immunol 289: 151-173.
24. Zhang Y, Ting AT, Marcu KB, Bliska JB, (2005) Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J Immunol 174: 7939-7949.
25. Lemaitre N, Sebbane F, Long D, Hinnebusch BJ, (2006) Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun 74: 5126-5131.
26. Thanos D, Maniatis T, (1995) NF-kappa B: a lesson in family values. Cell 80: 529-532.
27. Bartfeld S, Hess S, Bauer B, Machuy N, Ogilvie LA, et al. (2010) High-throughput and single-cell imaging of NF-kappaB oscillations using monoclonal cell lines. BMC Cell Biol 11: 21.
28. Strom E, Sathe S, Komarov PG, Chernova OB, Pavlovska I, et al. (2006) Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2: 474-479.
29. Saadane A, Masters S, DiDonato J, Li J, Berger M, (2007) Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am J Respir Cell Mol Biol 36: 728-736.
30. Bosio CM, Goodyear AW, Dow SW, (2005) Early interaction of Yersinia pestis with APCs in the lung. J Immunol 175: 6750-6756.
31. Janssen WA, Surgalla MJ, (1969) Plague bacillus: survival within host phagocytes. Science 163: 950-952.
32. Lukaszewski RA, Kenny DJ, Taylor R, Rees DG, Hartley MG, et al. (2005) Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils. Infect Immun 73: 7142-7150.
33. Ponnusamy D, Clinkenbeard KD, (2012) Yersinia pestis Intracellular Parasitism of Macrophages from Hosts Exhibiting High and Low Severity of Plague. PLoS One 7: e42211.
34. Pujol C, Bliska JB, (2003) The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun 71: 5892-5899.
35. Straley SC, Harmon PA, (1984) Yersinia pestis grows within phagolysosomes in mouse peritoneal macrophages. Infect Immun 45: 655-659.
36. Rosenshine I, Duronio V, Finlay BB, (1992) Tyrosine protein kinase inhibitors block invasin-promoted bacterial uptake by epithelial cells. Infect Immun 60: 2211-2217.
37. Leo JC, Skurnik M, (2011) Adhesins of human pathogens from the genus yersinia. Adv Exp Med Biol 715: 1-15.
38. Scibelli A, Roperto S, Manna L, Pavone LM, Tafuri S, et al. (2007) Engagement of integrins as a cellular route of invasion by bacterial pathogens. Vet J 173: 482-491.
39. Kristiansen JE, Amaral L, (1997) The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 40: 319-327.
40. Chan YY, Ong YM, Chua KL, (2007) Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. Antimicrob Agents Chemother 51: 623-630.
41. Rani Basu L, Mazumdar K, Dutta NK, Karak P, Dastidar SG, (2005) Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine. Microbiol Res 160: 95-100.
42. Kaatz GW, Moudgal VV, Seo SM, Kristiansen JE, (2003) Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 47: 719-726.
43. Schesser K, Spiik AK, Dukuzumuremyi JM, Neurath MF, Pettersson S, et al. (1998) The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol 28: 1067-1079.
44. Sweet CR, Conlon J, Golenbock DT, Goguen J, Silverman N, (2007) YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Cell Microbiol 9: 2700-2715.
45. Zhang Y, Bliska JB, (2003) Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect Immun 71: 1513-1519.
46. Lee TK, Denny EM, Sanghvi JC, Gaston JE, Maynard ND, et al. (2009) A noisy paracrine signal determines the cellular NF-kappaB response to lipopolysaccharide. Sci Signal 2: ra65.
47. Jenkins AL, Worsham PL, Welkos SL, (2009) A strategy to verify the absence of the pgm locus in Yersinia pestis strain candidates for select agent exemption. J Microbiol Methods 77: 316-319.
48. Welkos S, Pitt ML, Martinez M, Friedlander A, Vogel P, et al. (2002) Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 20: 2206-2214.
49. Christensen DR, Hartman LJ, Loveless BM, Frye MS, Shipley MA, et al. (2006) Detection of biological threat agents by real-time PCR: comparison of assay performance on the R.A.P.I.D., the LightCycler, and the Smart Cycler platforms. Clin Chem 52: 141-145.
50. Conchas RF, Carniel E, (1990) A highly efficient electroporation system for transformation of Yersinia. Gene 87: 133-137.
51. Ihaka R, Gentleman R, (1996) R: A Language for Data Analysis and Graphics. Journal of Computational and Graphical Statistics 5: 299-314.